HEALTH FDA approves new blood test for colon cancer screening: ‘Early detection is critical’ Blood test can be performed in routine health care settings, has an 83% accuracy rate ...

The blood test, known as Shield and manufactured by Guardant Health, is already commercially available, but FDA approval ... improve colorectal cancer screening rates so we can detect more cancers ...

Early cancer detection often leads to less aggressive treatments, reduced recovery times and higher survival rates.

Shield is the first FDA-approved blood test for primary colorectal ... that would use blood samples to detect colorectal cancers. The device detects a colon cancer secreted protein known as ...

A routine blood test may be able to detect cancer more than three years before diagnosis, a new study suggests. In the study, published May 22 in Cancer Discovery, researchers at Johns Hopkins ...

A blood-based test has acceptable accuracy for colorectal cancer detection but not for advanced precancerous lesions in an ...

Scientists at Johns Hopkins University in the US have developed a new blood test that can detect signs of cancer up to three ...

While the previous PATHFINDER study—a prospective, year-long examination of about 6,600 people—showed that Galleri could more ...

Let’s make June a turning point where more people get screened, more cancers are caught early and fewer lives are lost.

Tiny, newly formed tumors shed small fragments of DNA that are swept into the bloodstream. Future cancer screening tests could detect them early.

Freenome has published data in JAMA from the pivotal trial of its blood-based test for colorectal cancer. The paper, which Freenome published Monday, contains similar key findings as the company’s ...